Paper700321
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
Bartlett JG and 4 others. Gastroenterology, 1978. Cited by 406 papers, by iCite.
Cite this record
ConductScience Library. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Papers, record 700321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/700321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Clostridium Infections | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Colitis, Ulcerative | |
| Cytotoxins | |
| Diarrhea | |
| Humans | |
| Infant, Newborn |
Source PubMed
Cited by165
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 406 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41039149 | Clostridioides difficile pathogenesis and control. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/41039149 | PubMed |
| 40833116 | Cysteine proteases and how YabG fits into clan CD of the MEROPS database. | J Bacteriol | 2025 | https://conductscience.org/library/papers/40833116 | PubMed |
| 40498310 | Methods of a Reproducible Mouse Model of Clostridioides difficile Infection to Investigate Novel Bacterial-Based Therapies. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40498310 | PubMed |
| 39912651 | Clostridioides difficile infection study models and prospectives for probing the microbe-host interface. | J Bacteriol | 2025 | https://conductscience.org/library/papers/39912651 | PubMed |
| 39847395 | Global burden and trends of the Clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study. | Ann Med | 2025 | https://conductscience.org/library/papers/39847395 | PubMed |
| 39452261 | Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39452261 | PubMed |
| 39203444 | Protective Effects of Huo Xiang Zheng Qi Liquid on Clostridioides difficile Infection on C57BL/6 Mice. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203444 | PubMed |
| 38470254 | CSPG4-dependent cytotoxicity for C. difficile TcdB is influenced by extracellular calcium and chondroitin sulfate. | mSphere | 2024 | https://conductscience.org/library/papers/38470254 | PubMed |
| 38399676 | Reviewing the Clostridioides difficile Mouse Model: Insights into Infection Mechanisms. | Microorganisms | 2024 | https://conductscience.org/library/papers/38399676 | PubMed |
| 38375101 | Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38375101 | PubMed |
| 38329351 | A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38329351 | PubMed |
| 37928470 | Prevalence of diagnostically-discrepant Clostridioides difficile clinical specimens: insights from longitudinal surveillance. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37928470 | PubMed |
| 37347682 | A local-scale One Health genomic surveillance of Clostridioides difficile demonstrates highly related strains from humans, canines, and the environment. | Microb Genom | 2023 | https://conductscience.org/library/papers/37347682 | PubMed |
| 37162717 | Trends in the epidemiology of Clostridioides difficile infection in Germany. | Infection | 2023 | https://conductscience.org/library/papers/37162717 | PubMed |
| 37101693 | Examining the Extent of Contamination, Antibiotic Resistance, and Genetic Diversity of Clostridioides (Clostridium) difficile Strains in Meat and Feces of Some Native Birds of Iran. | Biomed Res Int | 2023 | https://conductscience.org/library/papers/37101693 | PubMed |
| 36951574 | Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin. | J Bacteriol | 2023 | https://conductscience.org/library/papers/36951574 | PubMed |
| 36467633 | Isolation, molecular typing and antimicrobial resistance of Clostridium difficile in dogs and cats in Lanzhou city of Northwest China. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/36467633 | PubMed |
| 36415217 | Redefining genomic view of Clostridioides difficile through pangenome analysis and identification of drug targets from its core genome. | Drug Target Insights | 2022 | https://conductscience.org/library/papers/36415217 | PubMed |
| 35890064 | The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases. | Pathogens | 2022 | https://conductscience.org/library/papers/35890064 | PubMed |
| 35574602 | Probiotics: insights and new opportunities for Clostridioides difficile intervention. | Crit Rev Microbiol | 2023 | https://conductscience.org/library/papers/35574602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/700321
GET https://conductscience.org/api/papers/v1/700321/cited_by?page=2